From: Predicting COVID-19 disease progression and patient outcomes based on temporal deep learning
Survival class (general) | ||||
 Mean value | Stage 1 | Stage 2 | Stage 3 | Stage 4 |
 Mortality rate (%) | 7.57 | 0 | 1.91 | 0 |
 Time distance (days) | 22.65 | 14.08 | 7.98 | 2.75 |
 Lymph (%) | 16 | 18 | 21 | 31 |
 LDH (U/l) | 328 | 301 | 245 | 199 |
 hs-CRP (mg/l) | 43 | 39 | 21 | 3 |
 Indirect Bilirubin (μmol/l) | 7 | 6 | 4 | 3 |
 Creatinine (μmoI/l) | 98 | 75 | 89 | 76 |
 INR | 2 | 1 | 1 | 1 |
 Serum Sodium (mmol/l) | 138 | 139 | 140 | 137 |
 eGFR (ml/min) | 79 | 109 | 112 | 111 |
 Serum Chlorine (mmol/l) | 97 | 99 | 103 | 102 |
 Albumin (g/l) | 41 | 39 | 38 | 40 |
Death class (critical) | ||||
 Mean value | Stage 1 | Stage 2 | Stage 3 | Stage 4 |
 Mortality rate (%) | 76.32 | 88.76 | 91.28 | 100 |
 Time distance (days) | 26.96 | 18.76 | 9.32 | 2.05 |
 Lymph (%) | 15 | 10 | 9 | 4 |
 LDH (U/l) | 338 | 364 | 375 | 499 |
 hs-CRP (mg/l) | 48 | 55 | 69 | 84 |
 Indirect Bilirubin (μmol/l) | 8 | 9 | 14 | 23 |
 Creatinine (μmoI/l) | 104 | 106 | 120 | 125 |
 INR | 2 | 2 | 3 | 2 |
 Serum Sodium (mmol/l) | 140 | 140 | 135 | 129 |
 eGFR (ml/min) | 75 | 71 | 70 | 57 |
 Serum Chloride (mmol/l) | 96 | 103 | 104 | 105 |
 Albumin (g/l) | 40 | 32 | 33 | 32 |